Sirolimus topical formulation

N/A

Report date: 2026/03/03 16:17:28

Base Information

Drug NameSirolimus topical formulation
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionmTOR Complex 2 inhibitorsMammalian target of Rapamycin (mTORC1) inhibitors
TargetsmTOR Complex 2Mammalian target of Rapamycin (mTORC1)
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuoin Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUniversity College CorkQuoin Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A